homepage slider 4 of vascular innovations

homepage slider 1 of vascular innovations

homepage slider 2 of vascular innovations

homepage slider 3 of vascular innovations

About Us

Vascular Innovations Co., Ltd. is a design, development and manufacturing company focused on the cogenital and structural heart disease market place. The primary focus is to design products that facilitate the correction of defects in the heart. These defects include malformations, degeneration of structures and/or mechanical defects.

Product Portfolio

congenital heart defect explained by vascular innovations

Closure devices for congenital heart defect

A congenital heart defect or congenital heart disease, is a problem in the structure of the heart that is present at birth. These defects are closed by minimally invasive techniques. Closure devices include the Cocoon Septal Occluder, Cocoon Duct Occluder, Cocoon VSD Occluder and Cocoon PFO Occluder.

Transcatheter bioprostheses

A diseased valve can be replaced by a surgical or a transcatheter procedure. Transcatheter valve implantation is a minimally invasive procedure to repair a diseased valve without removing the old damaged valve and may be an option for people who are considered to be at high risk for surgical procedure.

Interventional loop - Snare systems

Snare system are small retrieval loop used in interventional cardiology and radiology.

News

SMT announces entry in Structural Heart Segment with the acquisition of Vascular Concepts Group

European (CE Mark) Approval for HYDRA Aortic Valve

HYDRA Aortic Valve approved for use in European countries. Please contact us at info@vascularinnovations.com for futher information

Change of Notified Body for Vascular Innovations

Vascular Innovations has changed its notified body for ISO 13485 and CE marking to PCBC since 2019. Please contact us at info@vascularinnovations.com to get a copy of the certificate.